Thyroid Neoplasms

Oncology
2
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%
+ 1 programs with unclassified modality

On Market (1)

Approved therapies currently available

E
LENVIMAApproved
lenvatinib
Eisai
Kinase Inhibitor [EPC]oral2015

Competitive Landscape

2 companies ranked by most advanced pipeline stage

E
EisaiChina - Liaoning
2 programs
1
LenvatinibPhase 4Small Molecule1 trial
LenvatinibN/ASmall Molecule1 trial
Active Trials
NCT02430714Completed629Est. Nov 2016
NCT03573960Completed50Est. Sep 2025
CT
1 program
Anlotinib Hydrochloride CapsuleN/A1 trial
Active Trials
NCT05994365RecruitingEst. Dec 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
EisaiLenvatinib
Chia Tai TianQing Pharmaceutical GroupAnlotinib Hydrochloride Capsule
EisaiLenvatinib

Clinical Trials (3)

Total enrollment: 679 patients across 3 trials

NCT03573960EisaiLenvatinib

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Start: Apr 2018Est. completion: Sep 202550 patients
Phase 4Completed
NCT05994365Chia Tai TianQing Pharmaceutical GroupAnlotinib Hydrochloride Capsule

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

Start: Aug 2023Est. completion: Dec 2028
N/ARecruiting
NCT02430714EisaiLenvatinib

Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

Start: May 2015Est. completion: Nov 2016629 patients
N/ACompleted

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
2h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
2h ago

Office Administrator

SystImmune
2h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
3h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
3h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
3h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 679 patients
Small Molecule is the dominant modality (100% of programs)
2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)